Insmed Inc

NASDAQ:INSM   1:28:45 PM EDT
21.81
-0.97 (-4.26%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.62B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$66.93 Million
Adjusted EPS-$0.88
See more estimates
10-Day MA$22.45
50-Day MA$24.29
200-Day MA$23.06
See more pivots

Insmed Inc Stock, NASDAQ:INSM

700 US Highway 202/206, Building 10, Bridgewater, New Jersey 08807-3365
United States of America
Phone: +1.908.977.9900
Number of Employees: 613

Description

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.